{"id":240,"date":"2026-08-14T05:01:59","date_gmt":"2026-08-14T05:01:59","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dental-practice-transition-timeline\/"},"modified":"2026-08-14T05:01:59","modified_gmt":"2026-08-14T05:01:59","slug":"dental-practice-transition-timeline","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-practice-transition-timeline\/","title":{"rendered":"Ideal Timeline to Plan a Dental Practice Transition and Sale"},"content":{"rendered":"<h2>Key Planning Lessons for Dental Practice Owners<\/h2>\n<ul>\n<li>\n<p>Begin transition planning 2\u20135 years before your target exit date to pursue 15\u201330% higher sale prices than sellers who list within 12 months.<\/p>\n<\/li>\n<li>\n<p>DSO-bound practices ($1.5M+ revenue) often need a 3\u20135-year runway, while doctor-to-doctor sales ($1M\u2013$1.5M revenue) typically require 18\u201324 months of preparation.<\/p>\n<\/li>\n<li>\n<p>A CPA-led EBITDA valuation is a crucial first step that clarifies true profitability and can prevent buyers from re-trading the price later.<\/p>\n<\/li>\n<li>\n<p>Running a competitive, multi-buyer process with a dental-specific advisor can deliver approximately 30% higher valuations than selling independently.<\/p>\n<\/li>\n<li>\n<p>Whether your target exit is two years away or five, talk with <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">McLerran &amp; Associates in a confidential discovery call<\/a> to understand your options and timeline.<\/p>\n<\/li>\n<\/ul>\n<h2>Recommended Start Timeline by Practice Type<\/h2>\n<p>The right lead time before marketing a dental practice depends mainly on revenue, likely buyer type, and how much preparation remains. The table below contrasts the two primary transition paths at a high level. Every figure is drawn from published market data and McLerran &amp; Associates&#8217; transaction experience.<\/p>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Practice Profile<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Recommended Lead Time<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Key First Step<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>DSO-bound ($1.5M+ revenue, $250K+ EBITDA)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>3\u20135 years<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>CPA-led EBITDA analysis, begin reducing owner-doctor production share<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Doctor-to-doctor ($1M\u2013$1.5M revenue)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>18\u201324 months<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Comprehensive practice valuation, assemble sell-side advisor team<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Find out which timeline applies to your practice and what your first step should be, and <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">schedule a free, confidential discovery call with McLerran &amp; Associates<\/a>.<\/p>\n<h2>Market Landscape: From Solo Successions to DSO Affiliations<\/h2>\n<p>For most of dental history, practice transitions followed a simple pattern: one dentist sold to another. That landscape has shifted substantially over the past decade. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.beckersdental.com\/benchmarking\/16-of-us-dentists-affiliated-with-a-dso-state-by-state-breakdown\/\">ADA Health Policy Institute data show that 16.1% of U.S. dentists were affiliated with a DSO in 2024, up from 7.2% in 2015<\/a>, while <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/us-dental-practice-ownership-2026\">the dentist-owner share of active U.S. practices declined from 84.7% in 2005 to 72.5% in 2023.<\/a><\/p>\n<p>Demand from institutional buyers remains strong. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.beckersdental.com\/dso-dpms\/69-of-dsos-plan-to-boost-acquisitions-in-2026-report\/\">About 69% of surveyed DSOs report that their private equity sponsors expect a moderate or high increase in acquisition activity in 2026<\/a>, while 78% of buyers anticipate recapitalization within 12\u201336 months. At the same time, the largest retirement-age cohort in dentistry is approaching transition simultaneously, which can eventually compress seller leverage as supply normalizes.<\/p>\n<p>The practical implication is clear. Owners of premier practices who begin planning now, rather than waiting for retirement to force the timeline, can position themselves to transact in a seller-favorable window. To use this window well, owners benefit from a structured, stepwise approach.<\/p>\n<h2>Phase 1: Clarify Your Transition Paths and Valuation<\/h2>\n<p>The first phase focuses on education and valuation, not marketing. Before any buyer conversation, an owner benefits from a defensible, CPA-led EBITDA analysis that can hold up under buyer scrutiny, rather than a free, rough estimate that becomes an anchor a buyer uses to negotiate the price down.<\/p>\n<p>McLerran &amp; Associates builds this analysis from the ground up. The team remotely accesses practice management software, cross-references financial statements, and reviews every discretionary, personal, and non-recurring expense to arrive at a view of true profitability. This creates diligence-grade work before the deal goes to market, so buyers have less room to re-trade the numbers later.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p>The two main transition paths carry different preparation requirements.<\/p>\n<p>For owners targeting a DSO affiliation, generally with $1.5M+ in revenue, a 3\u20135-year runway can be a high-impact starting point. Key preparation steps for this path include:<\/p>\n<ul>\n<li>\n<p>Move to accrual-basis accounting and prepare monthly profit-and-loss statements for the prior three years, since buyers often rely on this level of detail during diligence.<\/p>\n<\/li>\n<li>\n<p>Build a documented add-back log with supporting invoices to support your adjusted EBITDA calculation.<\/p>\n<\/li>\n<li>\n<p>Hire an associate 18\u201324 months before sale to reduce owner-doctor production below 35% of collections, which can help avoid a 1.0x\u20132.0x EBITDA multiple reduction when production is concentrated in the seller.<\/p>\n<\/li>\n<li>\n<p>Initiate PPO fee renegotiations 12\u201318 months before marketing, because these cycles often require that amount of time to complete and can affect revenue.<\/p>\n<\/li>\n<li>\n<p>Build hygiene recall rates toward 85%+ and document systems to reduce owner dependency, which can make the practice more durable in a buyer\u2019s eyes.<\/p>\n<\/li>\n<li>\n<p>Engage a dental-transaction CPA and attorney at least two years before the planned sale so tax and legal structures support your goals.<\/p>\n<\/li>\n<\/ul>\n<p>For owners targeting a doctor-to-doctor sale, generally with $1M\u2013$1.5M in revenue, an 18\u201324-month preparation window is often sufficient. Key steps include:<\/p>\n<ul>\n<li>\n<p>Obtain a comprehensive practice valuation from a dental-specific advisor to understand realistic pricing.<\/p>\n<\/li>\n<li>\n<p>Gather three years of profit-and-loss statements and tax returns so buyers can review consistent financial history.<\/p>\n<\/li>\n<li>\n<p>Address any deferred equipment maintenance that could reduce buyer confidence or trigger price reductions.<\/p>\n<\/li>\n<li>\n<p>Secure favorable lease terms on the practice location, since lease risk can affect buyer interest and financing.<\/p>\n<\/li>\n<li>\n<p>Strengthen the hygiene program and active patient count to demonstrate stable or growing demand.<\/p>\n<\/li>\n<li>\n<p>Assemble a sell-side advisor, dental-transaction attorney, and CPA to guide negotiations and structure.<\/p>\n<\/li>\n<\/ul>\n<h2>Phase 2: Run a Competitive Buyer Process<\/h2>\n<p>A seller who approaches a single buyer, or allows a buyer to set the opening valuation, often negotiates from a structural disadvantage. A structured, competitive process among multiple vetted buyers can create upward pressure on both price and terms.<\/p>\n<p>McLerran &amp; Associates runs this process for both DSO and private-buyer paths. On the DSO side, the firm builds a marketing deck and virtual data room, then solicits offers from a pre-vetted pool of institutional buyers, often generating around 10 offers within a 45\u201360-day window. Poorly run or undercapitalized buyers are removed before the process begins, so owners see only well-backed, well-run partners. Market data show that final transaction values can average significantly above initial offers when a competitive process is run correctly.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<p>On the private-buyer side, McLerran accesses a large pool of pre-qualified individual dentists to generate competing interest and pursue at- or above-ask offers. This competitive structure has helped McLerran clients achieve, on average, approximately 30% higher valuations than owners who sell on their own.<\/p>\n<h2>Phase 3: Evaluate Buyer Fit and Long-Term Alignment<\/h2>\n<p>Price is one dimension of outcome. Fit, meaning alignment between a buyer&#8217;s strategy, culture, and support model and what the selling owner wants for patients, staff, and legacy, can be just as significant. The highest bidder is not always the right buyer.<\/p>\n<p>On the DSO path, fit involves evaluating a buyer as both a partner and an investment. DSO deals typically structure a portion of the purchase price as cash at closing, with the remainder as contingent earnouts and equity rollover. The owner is effectively buying stock in the DSO and can benefit from evaluating it accordingly. Key questions include whether the platform is profitable, whether revenue is growing at existing locations, whether the management team is experienced, and whether the private equity backing appears stable.<\/p>\n<p>McLerran vets buyers with this investment lens, steering owners toward well-backed partners with a track record of satisfied sellers and away from undercapitalized platforms that can put retained equity at risk. Second-bite exits on DSO rollover equity can deliver 1.5x\u20133x returns for well-run platforms, although roughly 15\u201320% of platforms underperform and may deliver smaller or no returns.<\/p>\n<h2>Phase 4: Protect Value Through Diligence and Closing<\/h2>\n<p>Maximizing outcome means defending the agreed value all the way through closing, not just securing a strong letter of intent (LOI). On many DSO transactions, McLerran provides quality-of-earnings defense. When a buyer&#8217;s diligence team scrutinizes the EBITDA analysis, McLerran defends the numbers it underwrote and reminds buyers that other vetted bidders remain available if the deal is re-traded. Prepared sellers in DSO transactions often close at the LOI multiple, while unprepared sellers may close 5\u201315% below it or see the deal fail entirely.<\/p>\n<p>McLerran&#8217;s high transaction rate, noted earlier, reflects this end-to-end advocacy. The firm focuses on selling practices, not simply listing them.<\/p>\n<p>Discuss where your practice stands across all four phases, and <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">schedule a discovery call with McLerran &amp; Associates<\/a> to map out a realistic timeline for your situation.<\/p>\n<h2>Strategic Deal Terms: Cash, Equity, Staff, and Post-Close Role<\/h2>\n<p>Several structural variables can materially affect what an owner actually walks away with, which can differ from the headline purchase price.<\/p>\n<p><strong>Cash-at-close vs. deferred consideration.<\/strong> As noted earlier, many DSO deals include a portion of the purchase price as cash at close with the remainder deferred or contingent. This structure shifts some post-close risk to the seller even when headline multiples appear similar. Doctor-to-doctor sales, by contrast, often deliver 80\u2013100% cash at closing with a post-close transition period of 30\u2013120 days.<\/p>\n<p><strong>Retained equity.<\/strong> Equity in a DSO deal can be held at the joint-venture level, which may include distributions and a lower ceiling, or at the holding-company level, which usually has no distributions but a higher potential upside at recapitalization. McLerran models each structure across 3-, 5-, 7-, and 10-year horizons so owners can compare estimated after-tax proceeds rather than focusing only on headline numbers.<\/p>\n<p><strong>Staff continuity.<\/strong> Patient retention during dental practice transition can average over 90% for well-managed handoffs versus 70\u201380% or lower for poorly managed ones. That swing can translate directly to practice revenue and, in earnout structures, to what the seller ultimately receives.<\/p>\n<p><strong>Post-close employment.<\/strong> Many DSOs now require a minimum 5-year post-close employment term in 2026, while doctor-to-doctor walk-away sales typically require only 4\u20138 weeks of transition support. These structural variables highlight why early preparation matters, because decisions made years in advance can shape which deal structures are available. Owners can factor their personal timeline and clinical goals into path selection more effectively when they plan ahead.<\/p>\n<h2>Current Best Practices for Financials, Advisors, and Goals<\/h2>\n<p>Regardless of which path an owner pursues, several preparation steps apply broadly and can help when started early.<\/p>\n<p><strong>Financial preparation<\/strong> includes moving to accrual-basis accounting, preparing three years of monthly profit-and-loss statements, building a documented add-back log, and auditing provider compensation classification. Buyer diligence now routinely includes doctor compensation normalization, which means recalculating EBITDA using market-rate doctor compensation. This review can lower reported EBITDA by 20% or more before applying the purchase multiple. Owners who address this proactively can guide the conversation, while those who wait often encounter it during diligence when leverage has shifted to the buyer.<\/p>\n<p><strong>Advisor team assembly<\/strong> typically includes a dental-specific sell-side advisor, a dental-transaction attorney, and a CPA familiar with dental mergers and acquisitions. Tax and legal structuring decisions made years in advance can move 15\u201330% of net-to-seller proceeds, so early engagement with the right advisors can be a high-return investment.<\/p>\n<p><strong>Goal documentation<\/strong> means writing down what a successful outcome looks like. Examples include target close date, minimum cash-at-close, post-close clinical role preferences, staff and patient continuity priorities, and geographic or buyer-type preferences. McLerran&#8217;s first step in every engagement is to understand an owner&#8217;s &#8220;why&#8221; before recommending any path.<\/p>\n<h2>Common Pitfalls and How to Avoid Them<\/h2>\n<p>Several patterns can consistently produce weaker outcomes for selling dentists when left unaddressed.<\/p>\n<ul>\n<li>\n<p><strong>Starting too late.<\/strong> Dentists who first obtain a valuation only 12 months before their target exit date may have limited time to address issues such as high PPO concentration or declining active patient counts, which can reduce sale price by $100,000\u2013$250,000.<\/p>\n<\/li>\n<li>\n<p><strong>Accepting a free valuation as the anchor.<\/strong> A rough number set by a buyer or a lead-generation firm often becomes the starting point for every negotiation. A CPA-led analysis can provide diligence-grade support that is more likely to hold up under scrutiny.<\/p>\n<\/li>\n<li>\n<p><strong>Talking to only one buyer.<\/strong> Without competitive tension, there is little mechanism to push price or terms upward. A single-buyer conversation often places the seller at a structural disadvantage.<\/p>\n<\/li>\n<li>\n<p><strong>High owner-doctor production concentration.<\/strong> Practices where the owner-doctor performs 90% or more of production can face a 10\u201320% valuation reduction because institutional buyers may not underwrite production that exits with the seller. Reducing this concentration usually requires a multi-year plan with associate development.<\/p>\n<\/li>\n<li>\n<p><strong>Ignoring payer mix.<\/strong> A 2026 dental practice with 50% or more Medicaid payer mix can experience a 15\u201325% compression in EBITDA multiple compared to fee-for-service practices, which can narrow the buyer universe significantly.<\/p>\n<\/li>\n<li>\n<p><strong>Underestimating deal fragility.<\/strong> Do-it-yourself close rates can run as low as 15\u201320%. Without an experienced advisor managing the process, deals may fall apart during diligence, financing, or final negotiation.<\/p>\n<\/li>\n<\/ul>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How far in advance should I start planning my dental practice transition?<\/h3>\n<p>The answer can depend on your practice&#8217;s revenue, EBITDA, likely buyer path, and current operational condition. As a general framework, owners targeting a DSO or private-equity affiliation often benefit from a 3\u20135-year runway, which can allow time to reduce owner-doctor production concentration, renegotiate payer contracts, build associate depth, and clean up financials before going to market. Owners targeting a doctor-to-doctor sale can often prepare adequately in 18\u201324 months. In both cases, a CPA-led valuation that establishes your true adjusted EBITDA can be the most important first step, because that number can influence your timeline, your path, and your realistic outcome range. If you are within five years of a planned transition, starting now can provide more options.<\/p>\n<h3>What is the difference between a DSO affiliation and a doctor-to-doctor sale, and how do I know which is right for me?<\/h3>\n<p>A doctor-to-doctor sale transfers ownership to another individual dentist, typically with 80\u2013100% cash at closing and a short 4\u20138-week transition period. A DSO affiliation transfers ownership to a corporate platform, often with 60\u201380% cash at closing, 15\u201330% in rollover equity, which is stock in the DSO, and a post-close employment commitment that commonly runs 3\u20135 years. DSO deals can offer higher headline valuations for larger, more profitable practices, but the deferred and contingent portions of the deal mean the realized outcome can depend heavily on the platform&#8217;s performance after closing. The right path can depend on your practice&#8217;s revenue and EBITDA, your personal timeline, your clinical goals after the transaction, and how you weigh immediate liquidity against potential upside from retained equity. Because McLerran &amp; Associates works both paths in roughly equal measure, the firm can produce a side-by-side valuation that quantifies your practice&#8217;s worth in both markets so you can choose with more complete information.<\/p>\n<h3>Why does it matter whether my sell-side advisor is dental-specific?<\/h3>\n<p>Dental practice mergers and acquisitions have their own valuation methods, buyer pool, diligence requirements, and deal structures that can differ from other healthcare or business sectors. EBITDA add-backs in dental transactions, such as owner compensation normalization, personal expenses, and non-recurring items, require familiarity with how dental practices operate day to day. Buyer relationships also matter. A dental-only advisor maintains ongoing relationships with a broad universe of qualified DSO and private-equity buyers, knows which platforms appear well-run and which do not, and has a reputation that can encourage buyers to bid more aggressively on its listings. Specialty dynamics, including how multiples and buyer demand vary across general dentistry, oral surgery, orthodontics, pediatric dentistry, and other specialties, require depth that a generalist advisor may not have. McLerran &amp; Associates has evaluated more than 10,000 dental practices over approximately 35 years, with a team carrying over 100 years of collective dental-industry experience. That depth can be the difference between a valuation that holds up in diligence and one that gets re-traded.<\/p>\n<h3>What happens if I am not ready to sell yet, and is it too early to get a valuation?<\/h3>\n<p>A valuation can be most useful when obtained early, because it establishes a baseline, highlights value gaps, and gives you time to address them before going to market. McLerran &amp; Associates will update a valuation for free one year after the initial engagement if an owner is not yet ready to transact. The discovery call and valuation process carry no obligation to sell. They serve as the foundation of an informed decision, not a commitment to one. Many owners who engage McLerran two or three years before their target exit date use the valuation to prioritize which operational improvements may move the needle most on their eventual sale price.<\/p>\n<h2>Conclusion: Start Your Transition Timeline with Informed Guidance<\/h2>\n<p>The ideal timeline to plan a dental practice transition and sale is not a fixed number of months. It depends on where your practice stands today, including revenue, EBITDA, owner-production concentration, payer mix, and operational condition, and where you want it to be when it goes to market. One principle remains consistent. Earlier preparation, anchored by a CPA-led valuation and guided by a dental-specific sell-side advisor who works both paths, can support stronger outcomes than waiting until the decision feels urgent.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<p>McLerran &amp; Associates&#8217; track record, which includes thousands of successful sales, billions in closed volume, and a transaction rate far above many industry norms, reflects a sell-side-only model where incentives align with the selling dentist rather than the buyer.<\/p>\n<p>Whether your target exit is two years away or five, the first step often remains the same. Clarify your options before committing to a path, and <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">contact McLerran &amp; Associates<\/a> to discuss your practice, your goals, and a timeline that can support a strong outcome.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn when to start planning your dental practice sale \u2014 18 months to 5 years out. McLerran helps you maximize value at every stage.<\/p>\n","protected":false},"author":1,"featured_media":239,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-240","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=240"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/240\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/239"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}